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Background: The study describes the application of the PCR method for the simultaneous detection of DNA of
Gram-negative bacteria, Gram-positive bacteria, yeast fungi and filamentous fungi in blood and, thus, a whole range of
microbial etiological agents that may cause sepsis. Material for the study was sterile blood inoculated with four species
of microorganisms (Escherichia coli, Staphylococcus aureus, Candida albicans and Aspergillus fumigatus) and blood
collected from patients with clinical symptoms of sepsis. The developed method is based on nested-multiplex
real-time PCR .
Results: Analysis of the obtained data shows that sensitivity of nested-multiplex real-time PCR remained at the level of
101 CFU/ml for each of the four studied species of microorganisms and the percentage of positive results of the
examined blood samples from the patients was 70% and 19% for the microbiological culture method. The designed
primers correctly typed the studied species as belonging to the groups of Gram-positive bacteria, Gram-negative
bacteria, yeast fungi, or filamentous fungi.
Conclusions: Results obtained by us indicated that the designed PCR methods: (1) allow to detect bacteria in whole
blood samples, (2) are much more sensitive than culture method, (3) allow differentiation of the main groups of
microorganisms within a few hours.
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Given the nonspecific clinical symptoms of sepsis, espe-
cially in its early stages, and the need for rapid imple-
mentation of appropriate therapy, microbiological and
laboratory testing is of importance. The key role in diag-
nostics is determining the etiological agent of infection.
Until now, the so-called diagnostic “gold standard” is
still blood cultures performed in specialized media, pre-
ferably in automated culture systems. An important
advantage of blood cultures is their low cost of testing.
However, the long period of waiting for the results, in
relation to the need for rapid implementation of appro-
priate antibiotic therapy, is undoubtedly a disadvantage
of this method. The downside is also its low sensitivity –
positive blood culture results, despite the presence of* Correspondence: tomasz.gosiewski@uj.edu.pl
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unless otherwise stated.clinical signs of sepsis, are obtained in less than 50% of
cases [1,2]. The situation is further exacerbated by sub-
jecting patients to antibiotherapy before the collection of
blood samples for culture – patients are often treated
with antibiotics before the symptoms of sepsis manifest
themselves. In such cases, cultures from blood are very
difficult to perform due to the fact that it contains anti-
biotics inhibiting the growth of microorganisms. The
detection of microbial nucleic acids is promising for ef-
fective, accurate and prompt diagnostics of bloodstream
infections. The sensitivity of molecular methods is much
higher than the sensitivity of the culture method, and,
what is more, prior employment of antibiotherapy does
not affect the test results [3]. Unfortunately, methods of
molecular biology also have their limitations. The diffi-
culty is caused by the isolation of DNA of suitable qual-
ity and high concentration from blood. An essential step
in isolating DNA from blood is bacterial and fungal cell
wall lysis of its cells present in the blood. However, bac-
teria and fungi display varying susceptibility to lysis. Theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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resistant to degradation, which results in the necessity of
employing mechanical disruption, chemical lysis, and
thermal lysis [4]. Another problem is the amplification
of microbial DNA isolated from blood which can be
inhibited by heme, its main component. This compound
causes dissociation of DNA polymerase which results in
disintegration of enzyme–substrate complex, and, ad-
ditionally, it blocks its catalytic pocket [5-7]. The listed
difficulties cause the market to lack solutions which have
applications in molecular diagnostics of sepsis. Although
it is possible to point out SeptiFast (Roche) kit which,
however, does not exhaust the possibilities offered by the
application of the diagnostic method based on PCR
[8,9]. Septifast (Roche) allows the detection of ten to
twenty species of bacteria and fungi, whose presence is
most often confirmed in patients’ blood. However, if sep-
sis is triggered by a bacterial or fungal etiological agent
from outside the list, the Septifast kit will generate a
negative test result, which may mislead the physician.
Consequently, the aim of the study was to develop an
alternative nested, multiplex, real time PCR (qPCR)
method serving to detect the presence of microbes in
blood in order to diagnose sepsis.
Results
Primers design
Four external primer sequences have been designed.
Their sequences are presented in Table 1. A test of the
designed primers was performed on DNA isolated from
the reference strains of the bacterial and fungal species
listed in the section “Reference microbial strains” and
amplification signal was obtained for all species, with no
cross-reaction of primers specific for bacteria to fungalTable 1 Sequences of primers and probes utilized in the stud
Amplification Oligonucleotide Sequence 5′ - 3′
I
*EXT_BAC_F kGCGrACGGGTGAGTAA
*EXT_BAC_R CGCATTTCACCGCTA
*EXT_FUN_F AATTGACGGAAGGGCACC
*EXT_FUN_R TTCCTCGTTGAAGAGCAA
II
**FUN_F TTGGTGGAGTGATTTGTCTGC
**FUN_R TCTAAGGGCATCACAGACCT
Candid_probe FAM-TTAACCTACTAAATAGT
Asperg_probe TexasRed-TCGGCCCTTAAAT
**GN/GP_F GACTCCTACGGGAGGC
**GN/GP_R GCGGCTGCTGGCAC
GP_Probe Hex- CTGAyssAGCAACGCCG
GN_Probe Cy5 –CCTGAysCAGCmATGC
β-actin gene
F GCCAGTGCCAGAAGAGCCA
R TTAGGGTTGCCCATAACAGC
*External primers; **internal primers; k = G/T; r = A/G.DNA and vice versa. The designed primers correctly
typed the studied reference strains species as belonging
to the groups of Gram-positive bacteria, Gram-negative
bacteria, yeast fungi, or filamentous fungi.The multiplex real-time PCR amplification standardization
The annealing temperature of the primers (amplification I)
was determined to be 46.0°C and for amplification
II – 65.0°C (Table 2). Afterwards, it was arranged that
magnesium ion concentration should equal 6.5 mM for
amplification I and 11.5 mM for amplification II. Com-
positions of the reaction mixtures were presented in
Table 2. Concentration of the used reagents were as
follows: external primers (Genomed) – 10 μM; internal
primers (Genomed) – 20 μM; TaqMan probes (Genomed) –
20 μM; Buffer B 10× (EURx); dNTP’s (EURx) – 2 mM;
MgCl2 (DNAGdansk) – 50 mM; Perpetual Taq Poly-
merase 2,5 U/μl (EURx). DNA amplification was carried
out under the following thermal conditions for amplifi-
cation I: 95°C for 5 min (95°C for 20 s, 46°C for 20 s, 72°C
for 30 s) 30 cycles and for amplification II: 95°C for 5 min
(95°C for 15 s, 65°C for 1 min) 40 cycles.Evaluation of the qPCR method sensitivity
The indication of sensitivity was performed separately
for amplification II (internal primers) and in the nested
system, i.e. in successive amplifications I and II. The ob-
tained results were compared in Table 3. These results
allow us to conclude that the use of amplification in the
nested system, i.e. successive amplifications I and II,
gives us the possibility to increase the detection sensi-
tivity by two orders of magnitude for reference strains
of filamentous, yeast fungi and for Gram-positive andy
Origin Target sequences
in this study
16S rRNA
in this study
in this study
18S rRNA
in this study
T
[11] 18S rRNA
G
GCTGCTAGC-BHQ1
AGCCCGGTCCGC-Eclipse
[10] 16S rRNA
CG –TAMRA (Q)
CGCG- BHQ-2
A
[16] β-actin gene
Table 2 The composition of the reaction mixtures, the reagents involved and PCR reaction thermal profiles
NESTED multiplex qPCR Multiplex qPCR
[final volume 50 μl]
I amplification II amplification
[final volume 25 μl] [final volume 10 μl]
1. H2O 6,7 μl 1. H2O 2,08 μl 1. H2O 0,4 μl
2. Buffer B 2,5 μl 2. Buffer B 1,0 μl 2. Buffer B 5,0 μl
3. EXT_BAC_F 0,125 3. GN/GP_F 0,2 μl 3. GN/GP_F 1,0 μl
4. EXT_BAC_R 0,125 4. GN/GP_R 0,2 μl 4. GN/GP_R 1,0 μl
5. EXT_FUN_F 0,125 5. GP_probe 0,05 μl 5. GP_probe 0,25 μl
6. EXT_FUN_R 0,125 6. GN_probe 0,05 μl 6. GN_probe 0,25 μl
7. dNTP’s 2,5 7. FUN_F 0,2 μl 7. FUN_F 1,0 μl
8. MgCl2 2,5 8. FUN_R 0,2 μl 8. FUN_R 1,0 μl
9. Polymerase Perpetual Taq 0,3 9. Asperg_prob 0,05 μl 9. Asperg_prob 0,25 μl
10. DNA 10 10. Candid_probe 0,05 μl 10. Candid_probe 0,25 μl
11. dNTP’s 1,0 μl 11. dNTP’s 5,0 μl
12. MgCl2 1,8 μl 12. MgCl2 9,0 μl
13. Polymerase Perpetual Taq 0,12 μl 13. Polymerase Perpetual Taq 0,6 μl
14. DNA (product of I amplification) 3,0 μl 14. DNA 25,0 μl
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tion II alone – functioning as an independent reaction.
The study of blood samples from patients using the
method of nested-multiplex qPCR, multiplex qPCR and
microbiological blood culture
102 blood samples from patients with clinical symptoms
of sepsis were examined with the use of the developed
method in the nested multiplex system and of BacT/
ALERT® 3D (bioMérieux) blood culture. The application
of the developed method for microbial detection allowed
to increase the percentage of positive results from 18.6%
as for culture to 69.6% in the case of nested-multiplex
qPCR (Table 4). The elaborated PCR method enabled us
to confirm the results of blood culture in every case and
assign group membership, being Gram-positive bacteria
or Gram-negative bacteria – yeast fungi presence was
confirmed in one case only by PCR (the presence of fila-
mentous fungi was not demonstrated). Mutliplex qPCR
(no nested-PCR) gave results of 17.6% which is a value
slightly lower than in the case of using culture methods
and just as nested PCR confirm the results of blood cul-
ture. In all 102 samples, amplification signal in negative
control was not obtained, which guarantees absence of
contamination. A detailed compilation of the results is
presented in Table 4.
Discussion
Molecular diagnostics of microbial etiological agents of
sepsis is currently at an initial stage and is limited more to
scientific research than to diagnostic practice. Only fewkits for the detection of microorganisms that cause sepsis
are available on the market: SeptiFast (Roche) and Septi-
Test (Molzym), but in no way do they satisfy the needs of
molecular sepsis diagnostics [8,9]. The SeptiFast (Roche)
system enables the detection of more than a dozen spe-
cific microbial species, while SeptiTest (Molzym) theo-
retically allows to detect every possible microorganism
species, but sequencing of the PCR product is required,
which increases the cost and prolongs the wait for the
result.
The starting point for the design of the described
nested-multiplex qPCR method was the work describing
the application of the qPCR method to detect bacteria
and fungi in biological materials separately – Bispo et al.
described the PCR methodology in the detection of bac-
teria with Gram differentiation in the vitreous humor,
and Sugita et al. described the PCR method for the de-
tection of yeast and filamentous fungi in the eyeball
when it is inflamed [10,11]. During the work carried out
by our team, it was possible to combine the sequences
of primers and probes described by the authors into a
multiplex reaction for simultaneous detection of bacteria
and fungi with their differentiation into Gram-negative
bacteria, Gram-positive bacteria, yeast fungi, and fila-
mentous fungi. The results of sensitivity determination
of such a method in the multiplex system has shown
that it is possible to achieve the detection threshold of
9.9 × 102 CFU/ml to 5.4 × 103 CFU/ml depending on the
group of microorganisms (Table 3). The resulting sensi-
tivity was lower than the one obtained using SeptiFast
(Roche) test with which one can detect the presence of
Table 3 Comparison of sensitivity of the nested multiplex PCR and multiplex PCR methods in real time
Microbe species Order of magnitude
[CFU/ml]
Detection limit of the
multiplex qPCR
Order of magnitude
[CFU/ml]
Detection limit of
the nested
multiplex qPCR
[CFU/ml]
*RFU level
105 104 103 102 101 100 [CFU/ml] 105 104 103 102 101 100
+ +
+ ∅ ∅ ∅
+ + + +
+ ∅ 100
A. fumigatus + + 3.7 × 103 ± 2.4 × 103 + + + + 3.7 × 101 ± 2.7 ×
102
(filamentous fungi) + + 3.2 × 103 CFU/reaction + + + + 1.2 CFU/reaction
+ + **CT (31.2-38.5) + + + + CT (29.1-32.2)
+ + + + + +
+ + +
∅ ∅
+ + + +
∅ 50
C. albicans + + + + 9.9 × 102 ± 3.4 × 103 + + + + + 8.5 × 101 ± 3.6 ×
102
(yeast) + + + + 9.5 × 101 CFU/reaction + + + + + 0.24 CFU/reaction
+ + + CT (33.3-37.2) + + + + + CT (29.7-32.1)
+ + + + + + + +
+ + +
∅ ∅ ∅
+ + + + +
+ 100
S. aureus + + + 4.5 × 103 ± 2.5 × 103 + + + + + 1.1 × 101 ± 3.7 ×
102
(Gram positive
bacteria)
+ + + 5.1 × 102 CFU/reaction + + + + + 0.78 CFU/reaction
+ + + CT (34.0-36.7) + + + + + CT (25.2-28.0)
+ + + + + + +
+ +
∅ ∅ ∅
+ + + + +
+ 30
E. coli + + + 5.4 × 103 ± 2.5 × 102 + + + + + 1.3 × 101 ± 3.7 ×
102
(Gram negative
bacteria)
+ + + 6.1 × 102 CFU/reaction + + + + + 0.73 CFU/reaction
+ + + CT (30.5-33.2) + + + + + CT (24.4-27.2)
+ + + + + + + +
“+”- the number of positive amplification results conducted in the five repetitions; “∅” – lack of amplification signal.
*RFU (relative fluorescence unit) signifies the value of the designated baseline.
**CT value, i.e. the consecutive reaction cycle number in which the linear increase of the product cut the established baseline RFU level.
Table 4 Comparison of the results obtained from blood of patients with clinical symptoms of sepsis by the method of
blood culture, the nested multiplex qPCR and the multiplex qPCR methods in the parentheses and the internal
inhibition control for the β-actin gene
Blood
culture
Nested-multiplex-qPCR (n = 102) Total
positive
samples
β-actin
gene(Multiplex-qPCR)
(n = 102) Gram positive Gram negative Yeast Filamentous fungi (n = 102)
43 51 1 0
(16) (18) (0) (0) 71
Positive 19 (18) 102
42.1 50.0 1 0
(15.7) (17.6) (0) (0) 69.6
% 18.6 (17.6) 100.0
“( )” – in the parentheses Multiplex-qPCR results.
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for E. coli, 3 × 101 CFU/ml for S. aureus, 3 × 101 CFU/ml
for C. albicans and 3 × 100 CFU/ml for A. fumigatus [12].
In order to increase the sensitivity of the detection
method in the multiplex qPCR system, a preliminary amp-
lification procedure (I) was designed so as to gain an
opportunity to carry out detection of the presence of bac-
teria and fungi in the nested multiplex qPCR system. The
designed primer sequences and amplification procedure
related to their use allowed to reduce the detection
threshold to approximately 101 CFU/ml for all of the four
examined groups of microorganisms (Table 3). The re-
sulting sensitivity is slightly lower than in the case of
SeptiFast (Roche) test, but it should be taken into account
that the number of cells of bacteria and fungi amplified in
the PCR reaction oscillate at a maximum of 7.8 CFU/reac-
tion, suggesting getting closer to the detection limit for
the established conditions of nested-multiplex qPCR amp-
lification (Table 3). Furthermore, in the SeptiFast (Roche)
system, internal transcribed spacer (ITS) was used as a tar-
get region for differentiating species of bacteria and fungi,
and not the sequences of 16S rRNA and 18S rRNA as in
the nested multiplex qPCR method; consequently, it is not
possible to directly compare the parameters of both
methods [13].
The examination of blood samples from patients with
clinical symptoms of sepsis, with the use of the developed
methodology, gave a percentage of positive results of
69.6% compared to 18.6% obtained with the method of
blood culture in the monitored culture system (Table 4).
This is a considerable difference, which may raise the
suspicion of false positive results, but which seems un-
likely, given the use of negative control, that in each case
gave a negative result. Specialized, universal media have
been used in blood culture for BacT/ALERT® 3D system
(bioMérieux) which could prevent the growth of certain
microbial species . This could impact on the low percen-
tage of positive results in the blood culture method. A
large proportion of positive samples indicates high sensi-
tivity of the nested-multiplex qPCR method in the diag-
nostics of microbiological agents that cause sepsis, but it
should be remembered that the samples came from pa-
tients who experienced clinical signs of sepsis, so there
was a high probability of bacteremia or fungemia. Similar
results have been shown by Chang et al. in their study
using SeptiFast (Roche) test, in which they demonstrated
the presence of bacteria in 75% of blood samples [14]. On
the other hand, the use of nested PCR increases the risk of
contamination of samples, which may lead to a more
frequent appearance of false positive results. Therefore,
samples which are positive by nested PCR, but negative by
culture may be tested by a third method (e.g. SeptiFast)
in order to rule out contamination. The blood culture
methods, even in automated systems, do not allow toobtain positive results of the culture in the majority of
cases, which does not exclude sepsis in patients [15]. The
detection of microorganisms in blood by multiplex qPCR
and its sensitivity were significantly lower (Tables 3 and 4).
Obviously, such results may suggest an occurrence of con-
tamination while drawing the blood sample, when bacteria
from the skin get into the sample. These are revealed at
the same time as the relevant etiological agent of sepsis
using the much more sensitive PCR method. In such a
situation, it would be necessary to differentiate the amplifi-
cation signal strength, to separate signals coming from the
contamination.
Conclusions
The method presented in this paper is based on a com-
bination of the nested and multiplex PCR methods
in order to obtain higher sensitivity; additionally, the
method allows to extend its scope over the whole panel
of bacterial and fungal microorganisms (with differenti-
ation of Gram-negative bacteria, Gram-positive bacteria,
yeast fungi, and filamentous fungi), but without typing
specific species. This information is very useful to the
physician when selecting the appropriate treatment be-
fore he receives the final identification from microbio-
logical laboratory.
Methods
Reference microbial strains
Several strains were used in the research: bacteria – Bacillus
sp. (ATCC 51912), Enterobacter aerogenes (ATCC 29009),
Enterococcus faecalis (ATCC 33186), Escherichia coli
(ATCC 25922), Haemophilus influenzae (DSM 4690),
Neisseria meningitidis (ATCC 53414), Proteus mirabilis
(DSM 4479), Pseudomonas aeruginosa (DSM 13626), Ser-
ratia marcescens (DSM 50904), Staphylococcus aureus
(ATCC 33497), Staphylococcus epidermidis (ATCC 35983),
Staphylococcus haemolyticus (DSM 20263), Streptococcus
agalactiae (DSM 2134), Streptococcus pneumoniae (ATCC
49619), Streptococcus pyogenes (DSM 20565), Streptococ-
cus salivarius (DSM 20617), fungi – Aspergillus fumigatus
(ATCC 14110), Candida albicans (ATCC 10231), Candida
glabrata (DSM 11950), Candida parapsilosis (DSM 5784),
Candida tropicalis (ATCC 20115).
Ethics statement and participants
The research was granted approval by the local Bioethics
Committee of the Jagiellonian University (KBET/94/B/
2009). Written informed consent was obtained from par-
ticipants before their enrollment in the study.
Blood samples
Blood was collected from volunteers, who had no clinical
symptoms of sepsis and no inflammatory markers (CRP,
OB). Additionally, 102 blood samples were taken from
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the John Paul II Hospital in Krakow. Blood samples were
drawn into 2-ml Vacutainer K3E (BectonDickinson) test
tubes.
Blood culture
The blood culture was carried out in the John Paul II
Hospital in Krakow in the Microbiology Department
using BacT/ALERT® 3D apparatus (bioMérieux).
DNA extraction of bacterial and fungal isolates
The bacterial and fungal DNA was isolated with the appli-
cation of a specialized kit for DNA extraction (Genomic
Mini, DNA Gdansk). The isolation was carried out in ac-
cordance with the manufacturer’s report.
The method for microbial DNA isolation from blood
With the aim of determining the sensitivity of the PCR
method, microbial DNA was isolated from 1.5-ml blood
samples, collected from volunteers, which were simultan-
eously inoculated with four model microbial reference
strains (E. coli, S. aureus, C. albicans, A. fumigatus) in order
to obtain a gradient of their number from 105 CFU/ml to
100 CFU/ml for each one of them. DNA isolation was car-
ried out according to the method described by Gosiewski
et al. with the employment of a ready-to-use Blood Mini
(A&A Biotechnology) kit [4]. The same method was used
to isolate DNA from blood samples of patients with clinical
symptoms of sepsis.
DNA purity and concentration
The concentration and purity of total DNA isolates in
the samples were measured spectrophotometrically at
wavelengths of A260 and A280. It was performed in a
NanoDrop machine (Thermo Scientific).
DNA amplification
All the processes of DNA amplification were performed
with the use of the real-time PCR method (qPCR) in a
CFX96 thermal cycler (BioRad) by employing species-
specific starters and TaqMan probes. The sequences of
oligonucleotides utilized in the research and amplifica-
tion procedures are presented in Table 1. Compositions
of the reaction mixtures and the thermal amplification
profiles were given in Table 2.
In each amplification reaction was used DNA isolated
from the sterile human blood samples derived from
healthy volunteers was used, serving as a PCR negative
control.
Additionally, in every sample of DNA isolated from
blood, β-actin gene detection was performed in order to
check whether qPCR inhibition takes place; SYBR®Green
JumpStart Taq ReadyMix (Sigma) was used for that pur-
pose [16] (Table 1).Primers design
16S rDNA and 18S rDNA sequences of the following or-
ganisms were obtained from GenBank (http://www.ncbi.
nlm.nih.gov/blast) provided in the public domain by the
National Center for Biotechnology: bacteria – Bacillus
thuringiensis (KC153529), Enterobacter aerogenes (AB84
4449), Enterococcus faecalis (KC150142), Escherichia sp.
(KF453959), Haemophilus influenzae (AB377170), Neis-
seria meningitidis (AJ239312), Proteus mirabilis (KC150
143), Pseudomonas sp. (JQ613981), Serratia marcescens
(KC130920), Staphylococcus aureus (CP000736.1), Staphy-
lococcus epidermidis (CP000029), Staphylococcus haemoly-
ticus (EF522132), Stenotrophomonas maltophilia (AB008
509), Streptococcus agalactiae (AB002480), Streptococcus
pneumoniae (CP000410.1), Streptococcus pyogenes (AB00
2521), Streptococcus salivarius (NR042776); fungi – Asco-
mycota sp. (JX869355), Aspergillus fumigatus (HQ871898),
Aspergillus sp. (KC120773), Candida albicans (JN941105),
Candida glabrata (AY083231), Candida parapsilosis (DQ
218328), Candida tropicalis (EU034726), Candida tuni-
siensis (JQ612155).
The universal external primers EXT_BAC_F and
EXT_BAC_R (for bacteria detection) and EXT_FUN_F
and EXT_FUN_R (for fungi detection) were designed by
aligning in the conservative region of 16S rDNA (bacteria)
or 18S rDNA (fungi), yielding products of approximately
610 bp and 440 bp. Selected sequences were aligned with
16S rDNA and 18S rDNA regions with the use of Chro-
masPro ver 1.7 (Technelysium Pty Ltd) software. The
designed primers were later tested using Multiple Primer
Analyzer (http://www.thermoscientificbio.com/webtools/
multipleprimer/) software in order to check whether they
form dimers or if they hybridize with one another. The
primer set and probes were described in Table 1.
The multiplex real-time amplification PCR standardization
The standardization of the method was carried out with
the use of DNA samples isolated from blood (taken from
healthy volunteers) simultaneously inoculated with four
model reference microbial strains (E. coli – Gram-negative
bacterium, S. aureus – Gram-positive bacterium, C. albi-
cans – yeast, A. fumigatus – filamentous fungus).
Optimization of the amplification method I was carried
out separately with external primers (EXT) and the ampli-
fication method II with internal primers and TaqMan
probes (Table 1). Optimization of the multiplex qPCR
method was based on the selection of the appropriate
concentration of magnesium ion concentration as well as
determining the appropriate temperature for all the four
pairs of primers and the four TaqMan probes to anneal to
the DNA matrix as regards amplification I and II (Table 1).
For this purpose, a series of experiments was performed
that tested the listed specific gradient factors: magnesium
ion concentration (1.5 mM – 16.5 mM); annealing
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II (56°C – 68°C).
Evaluation of the qPCR method sensitivity
The evaluation of the PCR method sensitivity consisted in
simultaneously inoculating the blood samples taken from
healthy volunteers with four reference strains (E. coli, S.
aureus, C. albicans, A. fumigatus) in the same blood
sample, so as to obtain a gradient of their number from
105 CFU/ml to 100 CFU/ml - as regards the resulting
gradient, we prepared 5 samples for each of the points
representing a specific number of microorganisms. Later,
DNA was isolated with the use of the methodology de-
scribed above. The indication of sensitivity was performed
separately for amplification II (external primers) and in
the nested system, i.e. in subsequent amplifications I and
II. The obtained results were compared in Table 3.
Amplification sensitivity was defined as the relation of
the CT value, i.e. the number of reaction cycle in which
the linear increase of the product cuts the established
baseline RFU (relative fluorescence unit) (Table 3).
Statistics
The relationship between the proportion positive from
each replicate of 5 and the corresponding log concentra-
tions of the four reference strains was examined using
probit regression analysis (Gretl software ver. 1.9.4.).
Using the probit model, the Nested qPCR and qPCR tests
were compared. A P value of <0.05 was taken as statisti-
cally significant.
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